Understanding How Tumor Cells Become Resistant to Picropodophyllin
Author Information
Author(s): Hashemi Jamileh, Worrall Claire, Vasilcanu Daiana, Fryknäs Mårten, Sulaiman Luqman, Karimi Mohsen, Weng Wen-Hui, Lui Weng-Onn, Rudduck Christina, Axelson Magnus, Jernberg-Wiklund Helena, Girnita Leonard, Larsson Olle, Larsson Catharina
Primary Institution: Karolinska Institutet
Hypothesis
What genetic changes occur in tumor cells that develop tolerance to the drug picropodophyllin (PPP) over time?
Conclusion
Long-term treatment with PPP leads to significant changes in gene expression and genomic alterations in tumor cells, contributing to their tolerance to the drug.
Supporting Evidence
- PPP treatment induced genomic alterations in tumor cells over a long period.
- Specific genes involved in cell death were found to be upregulated or downregulated in tolerant cells.
- Copy number variations were associated with changes in gene expression levels.
- Long-term exposure to PPP resulted in significant hypomethylation in tolerant cell lines.
Takeaway
Researchers studied how cancer cells adapt to a drug called picropodophyllin over time, finding that the cells change their genes to survive better against the drug.
Methodology
The study involved analyzing genomic alterations and gene expression changes in tumor cell lines treated with increasing doses of PPP over 80 weeks.
Potential Biases
Potential bias in the selection of cell lines and the interpretation of genomic data.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p=0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website